Category: Gastro-Hep News
In the Pipeline: Updates on Promising Agents in Development for Gastroenterology and Hepatology
Vedolizumab Biologics License Application for Ulcerative Colitis Gets Priority Review Status Priority review status of a Biologics License Application (BLA) for the humanized monoclonal antibody vedolizumab […]
September News
µTASWako i30 System for AFP-L3% and DCP Testing Cleared for Use in Canada The μTASWako i30 microfluid-based clinical immunoanalyzer (Wako Diagnostics) for serum lectin-reactive alpha-fetoprotein (AFP-L3%) […]
Highlights From Digestive Disease Week
Gastro-Hep News Normalization of Vitamin D Status May Reduce Risk of Surgery and Hospitalization in Patients with Inflammatory Bowel Disease Low plasma 25-hydroxy vitamin D (25[OH]D) […]
June News
Highlights From Digestive Disease Week Rectal Indomethacin Is Useful for Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis The most common major complication occurring after endoscopic retrograde cholangiopancreatography […]
May News
FibroScan to be Marketed in the United States The FibroScan 502 Touch device (EchoSens and Sandhill Scientific), including the M+ and XL probes, received 510(k) clearance […]
April News
Laparoscopic Adjustable Gastric Banding Resolves Metabolic Syndrome Laparoscopic adjustable gastric banding (LAGB) for weight loss was shown to resolve metabolic syndrome, according to researchers from the […]
February News
New ASGE Guidelines for Premalignant Esophageal Disease Surveillance The American Society for Gastrointestinal Endoscopy (ASGE) released new guidelines for endoscopy use in the early recognition and […]
December News
No Decrease in Long-Term Quality of Life for Liver Donors Given the shortage of livers from deceased donors, living-donor liver transplantation is becoming increasingly common. To […]
August News
Higher Levels of Hepatitis C Virus RNA Observed Among Men and African Americans A study published in the July issue of Hepatology identified several factors that […]
July News
ITPA Polymorphisms Predict Outcomes in HIV/HCV Co-Infected Patients Previous research has shown that single nucleotide polymorphisms (SNPs) in the inosine triphosphate pyrophosphatase (ITPA) gene are associated […]
May News
IL-28B Genotype and Early Viral Kinetic Response in Interferon-Free Hepatitis C Virus Therapy As reported in the April issue of Gastroenterology, Chu and colleagues conducted a […]
April News
Colonoscopic Polypectomy Reduces Mortality Due to Colorectal Cancer The premise underlying surveillance colonoscopy is that early detection and removal of cancerous polyps reduces both the incidence […]
AASLD Highlights
Abstract Summaries From the 62nd Annual Meeting of the American Association for the Study of Liver Diseases Efficacy of Long-Term Tenofovir Therapy in Patients with Chronic […]
December News
Colectomy for Ulcerative Colitis: Postoperative Complications and Mortality In order to determine the occurrence and severity of postoperative complications following colectomy and to identify factors that […]
November News
ILLUMINATE Study Results Support Response-Guided Therapy with Telaprevir In a new analysis of the ILLUMINATE study data, researchers found that a 24-week course of therapy with […]
July News
Endoscopic Mucosal Resection for Colonic Mucosal Neoplasia A prospective, multicenter, observational study conducted by the Australian Colonic Endoscopic Resection study group investigated whether endoscopic criteria can […]
June News
FDA Approves Boceprevir and Telaprevir for the Treatment of Hepatitis C Virus Infection On May 13, the US Food and Drug Administration announced its approval of […]
May News
Gluten Intolerance in Patients without Celiac Disease In a double-blind, randomized, placebo-controlled, dietary rechallenge trial, Biesiekierski and colleagues sought to determine whether gluten consumption can cause […]
April News
Quadruple Therapy Versus Standard Therapy for Eradication of Helicobacter pylori In an industry-sponsored, open-label, randomized, phase III trial, Malfertheiner and colleagues studied the efficacy and safety […]
March News
Reduced Dosing and Duration of Peginterferon α-2b for Genotype 2 or 3 Chronic Hepatitis C Patients A study by Manns and colleagues sought to evaluate whether […]